Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$25,584,720
-$3,317,552 QoQ
Shares Held
444,025
-6.8% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#243
of 2,506 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $673,665,379 across 15 Drug Manufacturers - General names. BMY ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
222,559 | $266,943,963 | |
| 2 | JNJ |
Johnson & Johnson
|
466,851 | $118,566,148 | |
| 3 | ABBV |
AbbVie Inc.
|
350,912 | $88,303,495 | |
| 4 | MRK |
Merck & Co., Inc.
|
473,483 | $60,842,565 | |
| 5 | AMGN |
Amgen Inc
|
133,818 | $48,458,174 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
238,168 | $30,090,145 | |
| 7 | PFE |
Pfizer Inc
|
1,108,420 | $26,690,753 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
444,025 | $25,584,720 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,584,720 | 444,025 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $28,902,272 | 476,542 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $22,906,160 | 424,660 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $18,306,495 | 405,909 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $19,024,403 | 410,983 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,199,079 | 363,979 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $18,887,589 | 333,939 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $16,689,720 | 322,569 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,180,832 | 317,381 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,826,374 | 291,838 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $14,236,934 | 277,469 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $14,941,759 | 257,439 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $16,256,601 | 254,208 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $17,952,953 | 259,024 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $18,253,355 | 253,695 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $15,606,672 | 219,534 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $13,208,657 | 171,541 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $10,682,828 | 146,280 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $9,002,217 | 144,382 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $10,134,045 | 171,270 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $12,216,901 | 182,833 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $16,495,300 | 261,291 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $16,343,478 | 263,477 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $15,692,040 | 260,276 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $16,349,281 | 278,049 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||